Celldex Therapeutics's chart data is dated 2026-10-09. Recorded technical signals: RSI rebound. There are 7 published signal records.
Celldex Therapeutics last closed at $29.89 (+2.01%) on 2026-10-09. Signals today: RSI rebound. Listed on Nasdaq. Trailing 12 months PER is -7.6×. Its overall grade ranks 443 of 738 stocks in Healthcare.
About this company
Celldex Therapeutics last closed at $29.89 (+2.01%) on 2026-10-09. Signals today: RSI rebound. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 443/738
Valuation grade B
Related stocks
- AmgenCompetitor
면역·염증 질환 및 항체/생물학적 제제 분야에서 경쟁
- Regeneron PharmaceuticalsCompetitor
항체 기반 바이오신약 개발 경쟁사
- SanofiCompetitor
면역질환·알레르기/염증 타깃 치료제 개발 경쟁
About Celldex Therapeutics
- What technical signals does Celldex Therapeutics (CLDX) have?
- Celldex Therapeutics current technical signals: RSI rebound.
- Is Celldex Therapeutics a cup-and-handle pattern?
- No. Celldex Therapeutics has no valid Cup signal right now.
- What published figures are available for Celldex Therapeutics?
- Market cap: $1.99B. Trailing 12 months PER: -7.6×. Latest quarter PBR: 3.19×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Celldex Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.